NOX 3.23% 9.6¢ noxopharm limited

Ann: Veyonda To Be Tested In Combination With Opdivo In Trial, page-8

  1. 1,077 Posts.
    lightbulb Created with Sketch. 92
    If say $1B currently equated to around $5 per share - and we were then talking about a BMS $3B offer - I would be more than happy with that. And as RBx pointed out, Novartis might want to claim a stake as well.

    Happy days.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.